ReviewReviews in cardiovascular medicine2026
Applications of Left Atrial Strain in Cardiovascular Disease: A Comprehensive Review of Recent Evidence.
Review in Reviews in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although left atrial (LA) function is of major clinical importance in cardiovascular diseases, traditional indicators such as LA volume struggle to promptly reflect functional changes. In recent years, the emerging technique of left atrial strain (LAS) has garnered widespread attention. As a quantitative metric based on speckle tracking echocardiography, LAS can detect subtle functional abnormalities in the LA myocardium at an early stage and independently assess atrial reservoir, conduit, and contraction functions beyond volume changes. Numerous recent studies have demonstrated the significant clinical utility of LAS across multiple cardiovascular conditions, including heart failure, atrial fibrillation, hypertension, valvular heart disease, and coronary artery disease. Furthermore, LAS exhibits prognostic value in cardiomyopathies and cancer therapy-related cardiotoxicity. This review summarizes recent advances in LAS across various cardiovascular diseases, objectively evaluates its clinical application prospects and limitations, and outlines future research directions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.